Krishna Institute of Medical Sciences Share Price Target 2026 Analyst Forecast Bull and Bear Case

Krishna Institute of Medical Sciences (NSE: KIMS) is a Super-Specialty Hospitals company trading at Rs 774.15 with a market capitalisation of Rs 13,293 crore. Analysts have set the Krishna Institute of Medical Sciences share price target at Rs 930 for 2026, based on FY27 earnings projections and sector re-rating potential. This article covers the complete 2026 price forecast for Krishna Institute of Medical Sciences including sector tailwinds, key risks, and the bull and bear scenarios.

Click Here – Get Free Investment Predictions

Krishna Institute of Medical Sciences Share Price Target 2026: Key Takeaways

• Krishna Institute of Medical Sciences share price target 2026: Rs 930 (20% upside from CMP Rs 774.15)
• Bull case: Rs 1,100 | Bear case: Rs 620
• Ticker: KIMS | Sector: Super-Specialty Hospitals | MCap: Rs 13,293 crore
• 52W range: Rs 601 to Rs 1,270 | PE: 30x
• Key catalyst: Q4 FY26 results and FY27 earnings recovery confirmation in 2026
• Key risk: FY27 earnings miss or sustained FII outflows from Indian equities

Krishna Institute of Medical Sciences Company Overview

Krishna Institute of Medical Sciences (NSE: KIMS) is a Hyderabad-based multi-specialty hospital chain operating 10 hospitals across Telangana, Andhra Pradesh, and Maharashtra with 3,500-plus beds, with FY26 revenue growing 20 percent year-on-year from surgical volumes and bed capacity addition. At CMP Rs 774.15 against a 52 week range of Rs 601 to Rs 1,270, the stock is trading at a meaningful discount to its 52 week high. The trailing PE is 30x and the Rs 930 analyst target implies approximately 20 percent upside from current levels. Compared to peers in hospitals like Yashoda Hospitals and Rainbow Children’s Medicare, Krishna Institute of Medical Sciences is positioned as a potential re-rating candidate on FY27 earnings delivery.

Parameter	Value
NSE Ticker	KIMS
Sector	Super-Specialty Hospitals
CMP (2026)	Rs 774.15
52 Week High	Rs 1,270
52 Week Low	Rs 601
Market Cap	Rs 13,293 crore
Trailing PE	30x
12-Month Analyst Target	Rs 930
Bull Case Target	Rs 1,100
Bear Case Target	Rs 620

Why Is the Krishna Institute of Medical Sciences Share Price Target Set at Rs 930 for 2026

FY27 Earnings Recovery and Revenue Acceleration

The Krishna Institute of Medical Sciences share price target of Rs 930 rests on analyst projections of 15 to 20 percent PAT growth in FY27. Q4 FY26 results released in 2026 confirming the earnings trajectory are the most direct catalyst for a re-rating. Until FY27 PAT delivery is confirmed, the Rs 930 price objective represents a base case with execution risk attached.

Structural Sector Tailwinds in Super-Specialty Hospitals

The Super-Specialty Hospitals sector is expanding on the back of India’s domestic demand growth, PLI scheme support, and rising corporate investment. Krishna Institute of Medical Sciences’s position among peers in hospitals like Yashoda Hospitals and Rainbow Children’s Medicare creates a structural growth runway. Sustained sector outperformance is one of the key conditions for the Rs 1,100 bull case to materialise, making sector monitoring essential for investors tracking this stock.

RBI Rate Cut Cycle and Lower Cost of Capital

India’s RBI rate cut cycle in 2026 is reducing borrowing costs across sectors and stimulating end market demand. For Krishna Institute of Medical Sciences, lower interest costs improve the EPS trajectory, narrowing the gap between current earnings and the FY27 estimates that underpin the Rs 930 analyst consensus. This rate environment is a tailwind across the Super-Specialty Hospitals space.

Union Budget 2026-27 Capex Push and Policy Support

Budget 2026-27’s Rs 11.21 lakh crore infrastructure capex, PLI scheme continuity, and consumption incentives create a favourable policy backdrop for Krishna Institute of Medical Sciences’s Super-Specialty Hospitals operations. Policy support increases the probability of Krishna Institute of Medical Sciences achieving its FY27 earnings targets, which in turn supports the Rs 930 price objective set by analysts for 2026.

FII Flow Normalisation After the 2026 Tariff Shock

As global macro conditions normalise through 2026, FII flows into quality Indian equities are gradually recovering. At 30x PE, Krishna Institute of Medical Sciences is positioned as a beneficiary of institutional reallocation into mid-cap and small-cap Indian stocks. Sustained FII inflow is a necessary condition for re-rating the stock toward the Rs 1,100 bull case scenario.

Krishna Institute of Medical Sciences Share Price Targets: Short Term, 12 Month, and Long Term

Short Term Krishna Institute of Medical Sciences Share Price Target

Near-term support for Krishna Institute of Medical Sciences is anchored near the 52 week low of Rs 601. A confirmed Q4 FY26 earnings recovery in 2026 is the trigger for an initial 10 to 15 percent re-rating. Investors eyeing a near-term entry can use the 52 week low as a key reference while awaiting the FY27 earnings confirmation that would strengthen the case for the full price objective of Rs 930.

12-Month Krishna Institute of Medical Sciences Share Price Target 2026

The 12-month Krishna Institute of Medical Sciences share price target 2026 is Rs 930, implying approximately 20 percent upside from CMP Rs 774.15. This base case assumes in-line FY27 earnings delivery and partial normalisation of FII flows. Investors can track live price movement on NSE under the ticker KIMS to assess progress toward this target.

Long Term Krishna Institute of Medical Sciences Share Price Target: FY27 to FY28

The long term Krishna Institute of Medical Sciences share price target for the FY27 to FY28 period is Rs 1,100 in the bull case. Full earnings delivery, re-rating toward higher peer multiples among peers in hospitals like Yashoda Hospitals and Rainbow Children’s Medicare, and sustained institutional buying are the three conditions that need to align for the stock to reach the Rs 1,100 level over a 2 to 3 year horizon.

Bull Case and Bear Case Scenarios for Krishna Institute of Medical Sciences in 2026

Bull Case Krishna Institute of Medical Sciences Share Price Target: Rs 1,100

The bull case Krishna Institute of Medical Sciences share price target of Rs 1,100 materialises when FY27 earnings beat analyst estimates, Super-Specialty Hospitals tailwinds accelerate beyond consensus, and FII flows return strongly to Indian equities. Under this scenario, Krishna Institute of Medical Sciences re-rates toward higher peer multiples, making Rs 1,100 achievable within FY28. The current gap between CMP Rs 774.15 and Rs 1,100 represents approximately 45 percent potential upside.

Bear Case Krishna Institute of Medical Sciences Share Price Target: Rs 620

The bear case Krishna Institute of Medical Sciences share price target of Rs 620 materialises if FY27 earnings disappoint, management guides below expectations, or sustained FII outflows depress the broader mid-cap market. Under this scenario, the stock risks testing the 52 week low support near Rs 601, and investors should reassess the investment thesis before adding more capital.

Scenario	Target	Key Conditions
Bull Case	Rs 1,100	FY27 earnings beat, sector re-rating, FII inflows
Base Case (Analyst Target)	Rs 930	In-line FY27 delivery, partial FII recovery
Bear Case	Rs 620	FY27 miss, guidance cut, FII outflows persist

Key Risks That Could Derail the Krishna Institute of Medical Sciences 2026 Price Objective

Global Macro and US Tariff Headwinds

The prolonged tariff tension triggered by the US reciprocal tariff announcement in 2026 has reduced FII risk appetite for Indian equities. A global demand slowdown or escalation in trade tensions remains the most prominent macro risk to the Krishna Institute of Medical Sciences share price target of Rs 930 and could push the stock toward the bear case of Rs 620.

FY27 Earnings Miss and Guidance Risk

Any FY27 earnings miss or downward guidance revision by Krishna Institute of Medical Sciences’s management would compress valuation multiples. This is the most direct company-specific risk to the Rs 930 analyst price objective. Investors should monitor quarterly results and management commentary closely, especially any signals about demand environment, pricing power, or margin compression in the Super-Specialty Hospitals segment.

Competitive Intensity Among Super-Specialty Hospitals Peers

Intensifying competition from peers in hospitals like Yashoda Hospitals and Rainbow Children’s Medicare could compress Krishna Institute of Medical Sciences’s market share and pricing power over the medium term. This structural risk must be weighed when assessing how defensible the earnings trajectory that underpins the Rs 930 analyst target truly is, particularly as new entrants and imports from China disrupt established market structures.

Liquidity Risk and FII Selling Pressure

Sustained FII outflows from Indian equities can delay the re-rating process regardless of company-level operational improvement. For smaller market cap stocks, liquidity constraints can amplify drawdowns significantly. Investors should size positions carefully and maintain stop losses to protect capital if the broader market de-rating continues through FY27.

How to Invest in Krishna Institute of Medical Sciences: A Step-by-Step Approach

Check the Univest Screener for live data

Before considering any investment based on the Krishna Institute of Medical Sciences share price target of Rs 930, review the company’s Q4 FY26 results and FY27 guidance released in 2026. Focus on revenue growth, operating margin trends, debt levels, and management commentary on Super-Specialty Hospitals sector demand and competition.

Open a Demat and trading account with a SEBI registered stockbroker to trade Krishna Institute of Medical Sciences (NSE: KIMS) with regulatory protection. Complete KYC, and before executing any order, study the competitive landscape among peers in hospitals like Yashoda Hospitals and Rainbow Children’s Medicare to assess whether Krishna Institute of Medical Sciences’s competitive position justifies the Rs 930 valuation.

Plan your entry using technical and fundamental triggers. The 52 week low of Rs 601 acts as a key support reference. A confirmed FY27 earnings uptick combined with positive guidance would validate the entry case. Always set a pre-defined stop loss below the 52 week low to limit downside.

Maintain position sizing discipline. Restrict any single stock to 3 to 5 percent of your total equity portfolio. This is especially important in the Super-Specialty Hospitals space where sectoral cycles, regulatory changes, and commodity price swings can amplify volatility beyond initial expectations.

Always consult a SEBI registered financial advisor before making investment decisions based on any analyst price target or market commentary. SEBI Registration No. INH000013776.

Download the Univest iOS App or the Univest Android App to track Krishna Institute of Medical Sciences’s live share price and receive daily stock recommendations from SEBI registered analysts.

FAQs on Krishna Institute of Medical Sciences Share Price Target 2026

What is the Krishna Institute of Medical Sciences share price target for 2026?

Ans. The Krishna Institute of Medical Sciences share price target 2026 is Rs 930, implying approximately 20 percent upside from CMP Rs 774.15. The bull case estimate is Rs 1,100 and the bear case is Rs 620.

What was the Krishna Institute of Medical Sciences share price target for 2025?

Ans. The 2025 price target for Krishna Institute of Medical Sciences was based on FY26 earnings projections. The current 2026 analyst consensus stands at Rs 930, reflecting FY27 growth potential from CMP Rs 774.15.

Is Krishna Institute of Medical Sciences a good investment at Rs 774.15?

Ans. At Rs 774.15, Krishna Institute of Medical Sciences offers potential upside toward Rs 930 if FY27 earnings recover as projected. Whether the stock is a good buy depends on individual risk appetite, investment horizon, and portfolio goals. Consult a SEBI registered financial advisor before investing.

What are the key risks to the Krishna Institute of Medical Sciences share price target 2026?

Ans. Key risks to the Krishna Institute of Medical Sciences share price target of Rs 930 include FY27 earnings miss, global tariff headwinds, sustained FII outflows, and competitive pressure in the Super-Specialty Hospitals sector. Monitoring quarterly results closely is essential.

What is the 52 week high and low of Krishna Institute of Medical Sciences?

Ans. The 52 week high of Krishna Institute of Medical Sciences is Rs 1,270 and the 52 week low is Rs 601. At CMP Rs 774.15, the stock is trading below its 52 week high and offers upside potential toward the Rs 930 analyst price objective.

What are the main growth catalysts for Krishna Institute of Medical Sciences in 2026?

Ans. Primary growth catalysts for Krishna Institute of Medical Sciences in 2026 include FY27 PAT recovery, Super-Specialty Hospitals sector tailwinds, RBI rate cuts reducing cost of capital, Union Budget 2026-27 policy support, and normalisation of FII flows into Indian equities.

How does Krishna Institute of Medical Sciences compare to its peers?

Ans. Krishna Institute of Medical Sciences operates in Super-Specialty Hospitals alongside peers in hospitals like Yashoda Hospitals and Rainbow Children’s Medicare. At CMP Rs 774.15 with MCap Rs 13,293 crore, the company is positioned as a potential re-rating candidate toward the Krishna Institute of Medical Sciences share price target of Rs 930 on FY27 earnings delivery.

What is the Krishna Institute of Medical Sciences share price target for 2027?

Ans. The long-term Krishna Institute of Medical Sciences share price target for FY27 to FY28 is Rs 1,100 in the bull case, assuming continued earnings growth, sector re-rating, and sustained FII inflows. Consult a SEBI registered financial advisor for personalised guidance.